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Abstract: Purpose The most frequent long-term complication after ileocecal resection in Crohn’s disease
is anastomotic recurrence and subsequent stenosis. Recurrence typically begins at the site of the anasto-
mosis, raising the question of whether the surgical technique of the anastomosis could affect recurrence
rates. Kono-S anastomosis is a hand-sewn antimesenteric functional end-to-end anastomosis that offers
a wide lumen that is well accessible for endoscopic dilatation. The purpose of our study is to review
the rate of postoperative complications almost 2 years after the introduction of this technique. Materials
and methods This is a prospective single-center cohort study of all consecutive patients with Crohn’s
disease undergoing ileocecal resection. Patients’ characteristics as well as specific data for the surgical
procedure and short-term outcome were evaluated. Results Thirty patients were operated for Crohn’s
disease of the terminal ileum (n = 24) or anastomotic recurrence (n = 6). Postoperative complications
with a Clavien-Dindo Score ฀ IIIb were observed in three patients. One patient showed a hemorrhage and
underwent surgical hemostasis. Two patients developed anastomotic leakage; in both cases, ileostomy
was created after resection of the anastomosis. The median hospital stay was 9 days (IQR 7–12). A com-
parison with a historic group of conventionally operated patients of our hospital revealed no differences in
short-term results except for the duration of surgery. Conclusion The Kono-S anastomosis is associated
with acceptable short-term results, complications, and recurrence rates comparable with the established
anastomotic techniques. Longer operation times are observed, but the few published studies concerning
long-term recurrence are promising.
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Abstract
Purpose The most frequent long-term complication after ileocecal resection in Crohn’s disease is anastomotic recurrence and
subsequent stenosis. Recurrence typically begins at the site of the anastomosis, raising the question of whether the surgical
technique of the anastomosis could affect recurrence rates. Kono-S anastomosis is a hand-sewn antimesenteric functional end-to-
end anastomosis that offers a wide lumen that is well accessible for endoscopic dilatation. The purpose of our study is to review
the rate of postoperative complications almost 2 years after the introduction of this technique.
Materials and methods This is a prospective single-center cohort study of all consecutive patients with Crohn’s disease under-
going ileocecal resection. Patients’ characteristics as well as specific data for the surgical procedure and short-term outcome were
evaluated.
Results Thirty patients were operated for Crohn’s disease of the terminal ileum (n = 24) or anastomotic recurrence (n = 6).
Postoperative complications with a Clavien-Dindo Score ≥ IIIb were observed in three patients. One patient showed a hemor-
rhage and underwent surgical hemostasis. Two patients developed anastomotic leakage; in both cases, ileostomy was created
after resection of the anastomosis. The median hospital stay was 9 days (IQR 7–12). A comparison with a historic group of
conventionally operated patients of our hospital revealed no differences in short-term results except for the duration of surgery.
Conclusion The Kono-S anastomosis is associated with acceptable short-term results, complications, and recurrence rates com-
parable with the established anastomotic techniques. Longer operation times are observed, but the few published studies
concerning long-term recurrence are promising.
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Introduction
Medical therapy has profoundly improved the course of
Crohn’s disease (CD) and reduced the need for surgical inter-
ventions. While previous data describe such a need in about
74–80% of patients, this number was lowered by 30% after
the introduction of infliximab [1–7]. After ileocecal resection,
50% of patients develop a recurrence, and reoperation rates
gradually increase over time [8, 9].
This increase raises the question of whether alterations in
the surgical technique may lead to lower reoperation rates.
Whether radical resection of the mesentery affects reoperation
rates in this way, as some authors have suggested, is currently
being determined by a randomized controlled trial
(NCT03769922) [10]. However, the most widely discussed
technique in surgery is anastomosis. The efficacy and safety
of the established types of anastomosis, such as end-to-end,
side-to-end, and side-to-side, have been demonstrated.
Comparison of stapled versus hand-sewn anastomosis with
respect to the need for repeat surgery failed to show the supe-
riority of one technique over the other [11, 12].
In 2003, Kono established a new technique in order to
reduce the rate of anastomotic strictures by recurrent CD
(Fig. 1) [3]. Preliminary results showed an impressively low
rate of recurrence requiring reoperation [13]. To date, there
have been few comparative cohort studies with side-to-end
and end-to-end anastomoses [14, 15]. In both comparisons,
Kono-S anastomosis led to fewer short-term complications
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Here, we present the first cohort of all consecutive CD
patients operated at a tertiary referral center for CD in our
country. Our present study aimed to corroborate the results
of earlier reports on the safety and efficacy of Kono-S anasto-
mosis with short-term morbidity and rates of anastomotic
leakage as the primary study endpoints.
Patients and methods
Patient selection
All consecutive patients with a diagnosis of CD undergoing
ileocecal resection at our hospital from April 2018 to October
2019 were included in this cohort study. All patients eligible
for ileocecal resection were offered the Kono-S anastomosis
without any specific selection criteria. Three certified colorec-
tal surgeons (K.H., A.R., and M.T.) performed the operations.
During the study period, no patient underwent ileocecal resec-
tion with another type of anastomosis.
All patients received regular follow-up either at our hospi-
tal or by their treating gastroenterologist. All patients provided
written, informed consent to the use of the Kono-S anastomo-
sis as well as the analysis of their healthcare data. Institutional
review board approval was provided (KEK-ZH-Nr. 2019-
00208). The work has been reported in line with the
STROCSS criteria [16].
Control group
The control group was retrospectively extracted from our hos-
pital database. All consecutive patients from March 2014 to
December 2017 were analyzed. Patients with an emergency
surgery were excluded as no certified colorectal surgeon per-
formed the procedure.
Follow-up
Most patients are regularly cared for and monitored in our
endoscopy department. Internal follow-up consists of a
Fig. 1 Surgical technique of Kono-S anastomosis. a The nearby mesen-
tery of the ileocecal region that is to be excised is divided at the mesen-
teric wall of the bowel. The dotted line indicates the resection lines. b The
intestine is transected by use of a linear staple cutter such that the mesen-
tery is in the middle of the staple line and at a 90° angle to it. c Then, the
staple lines are sutured together transversely to create a supporting col-
umn that is supposed to support the eventual dimension of the anastomo-
sis. d Longitudinal enterotomies of 7 cm length are then performed at the
antimesenteric aspect, beginning 1 cm from the supporting column. e The
anastomosis is then created transversely in hand-sewn fashion. The
backwall using a double-layer continuous manner, the front wall using
a single-layered continuous suture. All sutures with 4/0 PDS. f The pale
lines indicate the mesenteric side below the anastomosis with the
supporting column that is created with the proximal and distal bowel
stumps
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regular postoperative visit at 3 and 6 months after surgery. In
patients with external follow-up, we have requested documen-
tation on clinical and endoscopic course and recurrence from
the treating gastroenterologist.
Surgical technique
Following intraoperative definition of appropriate resection
margins, the transections of terminal ileum and colon are per-
formed with a linear stapler perpendicular to the mesentery
(Fig. 1). The center of the mesentery is thereby in the middle
of the stapler line, and the mesentery is at a right angle to the
stapler line. The opposing ends of the proximal and distal
segments are then stitched together at the corners: the two
stapler lines are sutured together using interrupted sutures
(PDS 3–0 or 4–0). In case of a length mismatch of the stapler
lines, the two sides are evenly distributed over the entire width.
The anastomosis is performed on the antimesenteric side of
the bowel: the bowel is opened lengthwise at a distance of
1 cm from the stapler line, and the opening is then pulled in
the lateral direction. The transverse opening needs to have a
length of at least 7 cm. The posterior wall of the anastomosis is
performed using a double-layer continuous suture and the an-
terior wall using a continuous single-layer suture (PDS 3–0 or
4–0). We did not measure the exact suturing time for the
anastomosis, but we performed a comparison between the
patient groups that each had exclusive ileocecal resection.
Statistical analysis
Data are presented in a descriptive and a comparative statisti-
cal manner. Quantitative data are presented with median and
interquartile range. Comparative data were analyzed with
SPSS version 26 (SPSS Inc., Chicago, IL). Comparison of
data was performed using chi-square test for categorical data
and Mann-Whitney U test for nonparametric data. A p value
of 0.05 was considered as statistically significant.
Results
From April 2018 to October 2019, 30 patients were eligible
for a reconstruction after ileocecal resection with a Kono-S
anastomosis. Patient characteristics are shown in Table 1
and show no difference to the control group with standard
anastomosis.
In all patients, the Kono-S technique was applied for an
ileocolic anastomosis after either primary ileocecal resection
or repeat resection of an ileocolic anastomosis. In 80% of
patients, the resection was their first surgical treatment of ab-
dominal CD. Median duration of the disease was 8 years. Five
patients (16.7%) had a serum albumin level below 30 g/l. In
another five cases (16.7%), preoperative albumin level was
missing. In the control group, two patients underwent surgery
for recurrent disease. Two patients of the control group
showed a serum albumin level below 30 g/l, and in another
twelve cases (40%), preoperative albumin level was missing.
In all but eight cases of each group, additional surgical
steps were necessary (e.g., extensive adhesiolysis or
intraoperative endoscopy; Table 2). In eight cases (26.7%)
of the Kono-S group, an additional anastomosis or suture
had to be performed for discontinuous Crohn’s enteritis or
fistula to the sigmoid colon: additional anastomosis was not
performed using the Kono-S technique. In one case, a fistula
to the bladder was resected and closed. Six patients (20%),
each of the Kono-S group of the control group, received a
diverting loop ileostomy (Table 3).
In 20 (66.7%) patients of the Kono-S group and in 14
(46.7%) of the control group, the ileocolic resection was per-
formed laparoscopically (p = 0.201). In ten patients (33.3%)
of the Kono-s group, the resection had to be performed open,
either due to interenteric abscess formation (n = 4), previous
operations (n = 5), and, in one patient, pregnancy at the time of
surgery (Table 2). One patient had to be converted to open
surgery after diagnostic laparoscopy due to an extended ab-
scess in the retroperitoneum. The Kono-S anastomosis was
performed extracorporeally in all cases. The length of opera-
tion was a median of 256 min (IQR 207.5–281.5). In eight
patients with exclusive laparoscopic IC resection (without ad-
ditional procedures to other sites of the bowel), the length of
operation was a median of 192.5 min (IQR 181–234) in the
Kono-S group and 155 min (154–176) in the control group
(p = 0.015).
Postoperative complications
Eighteen patients of the Kono-S group showed minor compli-
cations: most of them had a Clavien-Dindo score of I or II:
only one case of IIIa was observed (colonoscopy due to hem-
orrhage but without proof of bleeding). Three patients (10%)
developed postoperative major complications ≥ Clavien-
Dindo IIIb (Table 4). One patient suffered from a hemorrhage
from a divided mesentery in acute Crohn’s inflammation and
underwent reoperation to control the hemorrhage. Two pa-
tients suffered from anastomotic leakage (6.7%): both patients
received surgery for recurrence of CD. In one patient with
recurrent disease, we decided to forego a diverting ileostomy
due to her concurrent pregnancy. However, she had already
experienced a complicated course after initial ileocecal resec-
tion with anastomotic leakage. Five days after the creation of
the Kono-S anastomosis, inflammatory parameters increased,
and her clinical performance showed deterioration. The anas-
tomosis showed a small leak, which was repaired using exci-
sion and suture of the defect, and a diverting loop ileostomy
was performed. The other patient with a postoperative leak
had previously undergone radical surgery for rectal cancer
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and near-total colectomy with a remaining of 20 cm of colon
that was used as a colostomy. Due to recurrent CD, she had
further undergone several segmental small bowel resections
and had 120 cm of small bowel left. In order to preserve as
much bowel as possible, the remaining 20 cm of colon was
preserved, and a Kono-S anastomosis was created 20 cm be-
fore the colostomy. This patient had already shown an aggres-
sive course of CD in her previous history with multiple
enterocutaneous fistula. Ten days postoperatively, she
developed peritonitis and showed a broad leakage of the su-
ture and active colitis in the remaining colon. Completion
colectomy with end ileostomy was created, after which she
recovered uneventfully.
Follow-up
Concerning the Kono-S group, regular follow-up at our hos-
pital or by their treating gastroenterologist showed a median
Table 1 Demographic and







Gender f/m (% female) 14/16 (46.7% f) 13/17 (43.3% f) n.s.
Age (years [median; IQR]) 32 [27–46.5] 33 [27.3–43.3] n.s.
Primary resection/recurrence 24 (80%) / 6 (20%) 28 (93.3%)/2 (6.7%) n.s.
BMI [median; IQR] 23 [19.7–27.7] 22.6 [19.7–25] n.s.
Duration of disease (years [median; IQR]) 9.5 [3–15.5] 8 [3–14.8] n.s.
Perioperative medication
Prednisone; dose [median; range] 11 (36.7%); 11 (36.7%) n.s.
10 mg [2.5–20] 20 mg [11–43]
Budesonide 8 (26.7%) 10 (33.3%) n.s.
Thiopurines 6 (20%) 3 (10%) n.s.
Methotrexate 2 (6.7%) 0 n.s.
Biologics 19 (63.3%) 8 (26.7%) 0.008
Preoperative albumin level (g/l) [median IQR] 36 [30–38.5] 36.5 [31.8–40] n.s.
Current smoker 8 (26.7%) 7 (23.3%) n.s.
Preoperative interval between biologic
medication and surgery
Days (median) Days (median)
All patients (n = 19 vs. n = 8) 36.5 n.a.
Infliximab (n = 6 vs. n = 2) 41.5 1 × 42; 1× unknown n.a.
Vedolizumab (n = 4 vs. n = 2) 50 1 × 44; 1× unknown n.a.
Adalimumab (n = 3 vs. n = 3) 13 22; 1× unknown n.a.
Certolizumab (n = 2 vs. n = 1) 21 1 × 42 n.a.
Ustekinumab (n = 1 vs. n = 0) 42
Table 2 Procedural data





Laparoscopic resection 20 (66.7%) 14 (46.7%) n.s.
Length of surgery (min [median; IQR]) 256 [207.5–281.5] 206 [180–277] n.s.
Length of surgery in exclusive IC resection
(n = 8) (min [median; IQR])
192.5 [181–234] 155 [154–176] 0.015
Additional surgical intervention
Adhesiolysis 5 (16.7%) 6 (20%) n.s.
Stricturoplasty 2 (6.6%) 4 (13.3%) n.s.
Diverting ileostomy formation 6 (20%) 5 (16.7%) n.s.
Intra-abdominal abscess 5 (16.7%) 2 (6.7%) n.s.
Enterocolic fistula resection 5 (16.7%) 8 (26.7%) n.s.
Enterocutaneous fistula resection 1 (3.3%) 2 (6.7%) n.s.
Perianal fistula surgery 1 (3.3%) 0 n.s.
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follow-up of 10 months (IQR 5.5–13). During this follow-up,
16 patients (53.3%) had undergone colonoscopy following a
median 7 months (IQR 4–8.3) after surgery. In five of the
remaining 14 patients, an ultrasound was performed, after a
median interval of 6 months (IQR 5–11) to surgery.
Altogether, follow-up by ultrasound or endoscopy was per-
formed in 21 patients (70%). In three patients, endoscopic
recurrence was found with Rutgeerts score 2. Medical treat-
ment was initiated in these patients; there was no need for
endoscopic or surgical treatment in the brief follow-up period.
During follow-up, the ileostomy was closed in five of the six
patients who received one after Kono-S anastomosis. Median
time to reversal was 3 months (range 2–6 months).
The length of follow-up varies significantly between the
Kono-S and the control group, as does the rate of recurrence
(Table 5).
Discussion
The most common site of CD involvement is the terminal ileum
with a need for surgery in approximately half of cases [17, 18]. In
many cases, the disease has advanced to such an extent that
medical therapy can no longer offer relief, and surgery is the only
way to achieve remission [18]. In fact, ileocecal resection has
only recently been accepted as a choice of treatment in early as
well as late stages [7]. Whatever the conditions for the initial
ileocecal surgery, repeat resection due to symptomatic recurrence
becomes necessary in roughly half of the affected patients
[18–20]. This confronts surgeons with the question of whether
the operative strategy and technique of their initial work could
have been improved and thereby prevented the need for subse-
quent operations. [21]
Recurrence typically begins at the site of the anastomosis.
According to the literature, about 80% of patients develop an
endoscopic recurrence [3, 14]. Previous studies have shown that
the extent of the surgery with respect to the length of the resected
segment does not alter the rate of recurrence [11], shifting the
attention to the technique of anastomosis formation in CD [3].
While a large randomized trial and a Cochrane meta-
analysis showed no difference in recurrence rates after end-
to-end versus side-to-side anastomosis [11, 12], a subsequent
meta-analysis reported a significant advantage for side-to-side
anastomosis [22]. The contrasting recommendations of the
German guidelines (where all anastomotic techniques are con-
sidered to be equivalent) and the European Crohn’s and
Colitis Organization (ECCO) guidelines (where a clear rec-
ommendation is given for a wide side-to-side anastomosis)
mirror these conflicting results [23, 24]. In fact, only a few
randomized controlled trials could be included in the meta-
analysis, and evidence is still scarce [22, 25].
The more recent meta-analysis concludes that the larger
side-to-side anastomosis is preventive of recurrence [22]. If
increasing width of an anastomosis is preventive, the forma-
tion of a wide anastomosis should be the ultimate surgical
purpose in resections for CD [26].
The Kono-S anastomosis offers an antimesenteric side-to-side
suture technique that results in a large diameter, which should
presumably help prevent anastomotic stenosis in recurrent CD
[3]. In fact, all previous publications show impressively low
symptomatic recurrence rates (Table 6) [14]. The first published
randomized controlled trial by Luglio et al. demonstrated that






Minor complications (Clavien-Dindo < IIIb) 18 (62.1%) 21 (70%) n.s.
Major complications (Clavien-Dindo ≥ IIIb) 3 (10%) 3 (10%) n.s.
Reoperation 3 (10%) 3 (10%) n.s.
Anastomotic leakage 2 (6.7%) 3 (10%) n.s.
Hemorrhage with indication for surgical revision 2 (6.7%)
Length of hospital stay (days [median; IQR]) 9 [7–12] 9 [8–11] n.s.
Table 3 Indication for ileostomy
Indication for protective ileostomy Kono-S (n = 6) Control group (n = 6)
Serum albumin < 25 g/l 1
Immunosuppression > 40 mg prednisone 2 1
Immunosuppression 20 mg + low serum albumin (< 30 g/l) 2 1
Simultaneous sigmoid/rectal resection + ileocecal resection 1 3
Extended adhesiolysis – 1
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endoscopic and clinical recurrence rates are significantly lower
when using the Kono-S anastomosis compared with a standard
stapled ileocolic side-to-side anastomosis [27]. On a meta-level,
Alshantti et al. performed a systematic review and concluded that
a significant reduction in endoscopic and surgical recurrence can
be achieved using the Kono-S anastomosis [28]. However, it has
to be noted that endoscopic recurrences are considerably more
frequent than symptomatic recurrences [24]. An endoscopic re-
currence is primarily treated with medication. However, fixed
stenosis that may result from anastomotic recurrence is not ac-
cessible to medical treatment creating the need for endoscopic
intervention or repeat surgery [29, 30]. This remains the case,
despite the development of more potent medical therapies [7,
31]. The functional end-to-end configuration of theKono-S anas-
tomosis enables straightforward endoscopic access and with-
drawal, providing a true benefit for endoscopists [32].
Endoscopic dilatation may be the first interventional treatment
for stenosis of the anastomosis but is limited in angulated bowel
[33]. However, information on angulation of anastomotic stric-
tures is often lacking but may have important implications on
efficacy [34]. Therefore, the accessibility and technical feasibility
of a dilatationmust be ensured. In addition, endoscopic dilatation
is easier to perform after hand-sewn than after stapled
anastomoses.
The Kono-S anastomosis combines the wide technique of an
antimesenteric side-to-side hand-sewn suture with the straight
accessibility of an end-to-end anastomosis [3]. In our Kono-S
cohort, no symptomatic recurrence has occurred to date.
Follow-up is short, and further prognosis of our cohort would
be speculative. It is possible that over time, not only endoscopic
recurrences will occur in the Kono-S group but also individual
symptomatic surgical ones. In fact, the recurrence rate in the
literature after Kono-S anastomoses is below 2% as shown in
Table 6, while after classical surgical resection, symptomatic
recurrence may occur in 30% of patients, and 5% have to under-
go further surgical treatment within a year [31, 35]. In our series,
the length of follow-up is significantly different between the
Kono-S and the control group, so that the different rate of recur-
rence cannot be assessed conclusively, as it has to be assumed
that more recurrences occur over time.
The perioperative results of our study provide a more crit-
ical assessment of anastomosis than other cohort studies [19,
32]. Patient selection in our hospital was not restrictive in any
way. However, for patients at risk for anastomotic leakage, the
large suture length of the anastomosis may also imply an
increased risk of subsequent leakage. In fact, the leakage rate
of 6.7% in our cohort, which is in line with most studies on
ileocolic anastomoses, may not allow a firm conclusion due to
the small number of patients. In other cohorts, the leakage rate
in patients with Kono-S anastomosis is promisingly low ac-
cording to the few currently available studies.
There are some limitations of our study. First, the study was
not designed to be randomized from the beginning, and therefore,
the comparison with the historical group may be biased by
Table 6 Recurrence rates after Kono-S anastomosis
Author Year Number of patients Asymptomatic Recurrence Follow-up (months)
Clinical Endoscopic Surgical
Fichera [19] 2012 46 Unknown Unknown 11% 0 6.8
Katsuno [13] 2015 32 Unknown Unknown 61.2%* 0 a
Kono [3] 2011 69 Unknown Unknown 83% 0 b










Luglio [27] 2020 36 Unknown 8% at 12 mt
18% at 18 mt
22.2% 0 c
Seyfried [32] 2019 53 45.65% nn nn 0 12 (4–23)
aKatsuno: Follow-up for endoscopic recurrence: 14.8 months (3.-37); follow-up for surgical recurrence: 35 months (4–57)
bKono: endoscopic recurrence: 83% at 1-year follow-up; 100% endoscopic recurrence at 5 years follow-up







Follow-up (months [median; IQR]) 10 [5.5–13] 44 [26–55.8] < 0.001
Endoscopic recurrence 3 (10%) 16 (53.3%) 0.013
Rutgeerts score of recurrences (i2–4; [median; IQR]) 2 [2–2] 3 [2–4] n.s.
Reoperation for recurrence 0 2 (6.7%) n.s.
Langenbecks Arch Surg
factors other than the type of anastomosis. Secondly, the follow-
up is short, and therefore, no final assessment of the recurrence
rate can be made. A further weakness of our study is that we did
not measure the time for anastomosis. In fact, this factor may
hinder some to adopt this new technique. For better understand-
ing, we have listed additional operations that are performed in
Table 2, as these also prolong the operating time and have sep-
arately listed the average surgery time of patients who had only
undergone ileocecal resection. Although a shorter operation time
for the exclusive IC resection is shown and although we did not
specifically measure the exact time needed to complete the anas-
tomosis, it was felt to significantly lengthen the operation. The
comparison with the formerly performed stapled side-to-side
anastomosis at our department correspondingly shows a signifi-
cant longer operation time for Kono-S. There are no published
data on the length of surgery for Kono-S anastomosis compared
with other techniques, but themanifestly longer time neededmay
indeed be of concern for institutionswith tight elective schedules.
Conclusion
Firm recommendations as to whether the Kono-S anastomosis
should become the technique of choice following ileocolic
resection for CD would currently be premature, although the
first recently published randomized control trial supports its
use in such a context [27]. The few published reports, includ-
ing ours, highlight the potential advantages of this new tech-
nique but also underline the need for further research and
evidence [36].
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